428 related articles for article (PubMed ID: 37046585)
1. Current Applications of Liquid Biopsy in Gastrointestinal Cancer Disease-From Early Cancer Detection to Individualized Cancer Treatment.
David P; Mittelstädt A; Kouhestani D; Anthuber A; Kahlert C; Sohn K; Weber GF
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046585
[TBL] [Abstract][Full Text] [Related]
2. Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers.
Mondal D; Shinde S; Sinha V; Dixit V; Paul S; Gupta RK; Thakur S; Vishvakarma NK; Shukla D
Front Mol Biosci; 2024; 11():1385238. PubMed ID: 38770216
[TBL] [Abstract][Full Text] [Related]
3. Liquid Biopsy in Gastrointestinal Cancers.
Saini A; Pershad Y; Albadawi H; Kuo M; Alzubaidi S; Naidu S; Knuttinen MG; Oklu R
Diagnostics (Basel); 2018 Oct; 8(4):. PubMed ID: 30380690
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
5. Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis.
De Rubis G; Rajeev Krishnan S; Bebawy M
Trends Pharmacol Sci; 2019 Mar; 40(3):172-186. PubMed ID: 30736982
[TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
7. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy, the hype vs. hope in molecular and clinical oncology.
Mohanty A; Mohanty SK; Rout S; Pani C
Semin Oncol; 2021 Jun; 48(3):259-267. PubMed ID: 34384614
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.
Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y
Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361
[TBL] [Abstract][Full Text] [Related]
10. The potential of liquid biopsies in gastrointestinal cancer.
Wu C; Zhang J; Li H; Xu W; Zhang X
Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of liquid biopsies in gastrointestinal oncology.
Zhu J; Strickler JH
J Gastrointest Oncol; 2016 Oct; 7(5):675-686. PubMed ID: 27747082
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer.
Memarpour S; Khalili-Tanha G; Ghannad AA; Razavi MS; Joudi M; Joodi M; Ferns GA; Hassanian SM; Khazaei M; Avan A
Curr Cancer Drug Targets; 2021; 21(8):676-688. PubMed ID: 33719973
[TBL] [Abstract][Full Text] [Related]
13. Potential clinical utility of liquid biopsies in ovarian cancer.
Zhu JW; Charkhchi P; Akbari MR
Mol Cancer; 2022 May; 21(1):114. PubMed ID: 35545786
[TBL] [Abstract][Full Text] [Related]
14. Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications.
Shah UJ; Alsulimani A; Ahmad F; Mathkor DM; Alsaieedi A; Harakeh S; Nasiruddin M; Haque S
Biotechnol Genet Eng Rev; 2022 Oct; 38(2):339-383. PubMed ID: 35968863
[TBL] [Abstract][Full Text] [Related]
15. Current and future applications of liquid biopsy in non-small-cell lung cancer-a narrative review.
Tomasik B; Skrzypski M; Bieńkowski M; Dziadziuszko R; Jassem J
Transl Lung Cancer Res; 2023 Mar; 12(3):594-614. PubMed ID: 37057121
[TBL] [Abstract][Full Text] [Related]
16. Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA).
Lim M; Kim CJ; Sunkara V; Kim MH; Cho YK
Micromachines (Basel); 2018 Feb; 9(3):. PubMed ID: 30424034
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring.
Li W; Liu JB; Hou LK; Yu F; Zhang J; Wu W; Tang XM; Sun F; Lu HM; Deng J; Bai J; Li J; Wu CY; Lin QL; Lv ZW; Wang GR; Jiang GX; Ma YS; Fu D
Mol Cancer; 2022 Jan; 21(1):25. PubMed ID: 35057806
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.
Nordgård O; Tjensvoll K; Gilje B; Søreide K
Br J Surg; 2018 Jan; 105(2):e110-e120. PubMed ID: 29341153
[TBL] [Abstract][Full Text] [Related]
19. Liquid Biopsies, Novel Approaches and Future Directions.
Armakolas A; Kotsari M; Koskinas J
Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900369
[TBL] [Abstract][Full Text] [Related]
20. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
Muhanna N; Eu D; Chan HHL; Douglas C; Townson JL; Di Grappa MA; Mohamadi RM; Kelley SO; Bratman SV; Irish JC
BMC Cancer; 2021 Oct; 21(1):1075. PubMed ID: 34600526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]